Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2023 | How our expanding knowledge of pre-malignant conditions may impact clinical decision-making

Rena Buckstein • 10 Dec 2023
ASH 2023
General

Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, comments on whether the expanding knowledge around pre-malignant pathologies, namely clonal hematopoiesis of indeterminate potential (CHIP), may impact treatment approaches and clinical practice in patients with hematological malignancies. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Abbvie: Honoraria; Taiho: Honoraria, Research Funding; BMS: Honoraria, Research Funding.

More from Rena Buckstein

Unmet needs in LR-MDS: RBC transfusion-dependence
2:21
Unmet needs in LR-MDS: RBC transfusion-dependence
Rena Buckstein • 10 Dec 2023
Screening for CHIP to detect potential TMNs in cancer treatment
0:47
Screening for CHIP to detect potential TMNs in cancer treatment
Rena Buckstein • 10 Dec 2023
The impact of CHIP on clinical outcomes in older patients with lymphoma undergoing chemotherapy
3:24
The impact of CHIP on clinical outcomes in older patients with lymphoma undergoing chemotherapy
Rena Buckstein • 10 Dec 2023
Key highlights from iwMDS 2022
Key highlights from iwMDS 2022
Amer Zeidan et al. • 24 Jun 2022

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals